U.S. Markets close in 6 hrs 19 mins

Macy's, Inc. (M)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
25.86-0.19 (-0.73%)
As of 09:41AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Intermediate-term KST

Intermediate-term KST

Previous Close26.05
Bid0.00 x 1400
Ask0.00 x 1100
Day's Range25.36 - 25.88
52 Week Range12.00 - 37.95
Avg. Volume16,950,430
Market Cap7.739B
Beta (5Y Monthly)2.09
PE Ratio (TTM)9.62
EPS (TTM)2.69
Earnings DateFeb 21, 2022 - Feb 25, 2022
Forward Dividend & Yield0.60 (2.14%)
Ex-Dividend DateDec 14, 2021
1y Target Est34.83
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
-3% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for M

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Macy's Inc
    Weekly Stock ListInvestors wrapped up a quiet final week in 2021 with a modest loss for the S&P 500. But that hardly dented a strong year for stocks, when the S&P 500 climbed almost 27%. The average stock in the Argus Universe of Coverage rose 24% during the quarter, and the median stock advanced 36%. The average BUY-rated stock increased 28%, while the average HOLD-rated stock gained 15%. Will investors continue to favor value in 2021? Will small-caps reverse their recent weak trend? Given low interest rates, we expect growth stocks to resume outperformance over time. Investors seeking value are encouraged to focus on dividends and look for yields in the 3%-4% range. As for small-caps, the promise of the vaccine is encouraging for these companies, which typically don't have the gilt-edged balance sheets of large-caps and are thus more dependent on a strong U.S. economy. Small-cap valuations remain depressed, and this group looks to offer value into 2022.
    Fair Value
    Economic Moat
    15 days agoArgus Research
View more